44
Views
22
CrossRef citations to date
0
Altmetric
Original research

Response of spider leg veins to pulsed diode laser (810 nm): a clinical, histological and remission spectroscopy study

Pages 154-162 | Accepted 29 Jul 2003, Published online: 12 Jul 2009

References

  • Bernstein EF. Clinical characteristics of 500 consecutive patients presenting for laser removal of lower extremity spider veins. Dermatol Surg 2001; 27: 31–3.
  • Thibault P, Bray A, Wlodarczyk J, Lewis W. Cosmetic leg veins: evaluation using duplex venous imaging. Dermatol Surg Oncol 1990; 16: 612–18.
  • Sommer A, Van Mierlo PL, Neumann HA, Kessels AG. Red and blue telangiectases. Differences in oxygenation? Dermatol Surg 1997; 23: 55–9.
  • Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of pre-existing vessels. J Am Acad Dermatol 1997; 37: 523–49.
  • Hercogova J, Brazzini B, Hautmann G, et al. Laser treatment of cutaneous vascular lesions: face and leg telangiectases. J Eur Acad Dermatol Venereol 2002; 16: 12–18.
  • Major, A, Brazzini B, Campolmi P, et al. Nd:YAG 1064 nm laser in the treatment of facial and leg teleangiectasias. J Eur Acad Dermatol Venereol 2001; 15: 559–65.
  • Dee R. A logical approach to the injection treatment of varicose and spider veins. Conn Med 1999; 63: 391–8.
  • Green D. Sclerotherapy for varicose and telangiectatic veins. Am Fam Physician 1992; 46: 827–37.
  • Loo WJ, Lanigan SW. Recent advances in laser therapy for the treatment of cutaneous vascular disorders. Lasers Med Sci 2002; 17: 9–12.
  • Goldman MP. Treatment of leg veins with lasers and intense pulsed light. Preliminary considerations and a review of present technology. Dermatol Clin 2001; 19: 467–73.
  • Bihari I, Magyar E. Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg 2001; 27: 133–6.
  • Conrad P, Malouf GM, Stacey MC. The Australian polidcanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg 1995; 21: 334–6.
  • Hsai J, Lowery JA, Zelickson B. Treatment of leg telangiectases using a long pulsed dye laser at 595 nm. Laser Surg Med 1997; 20: 1–5.
  • West TB, Alster TS. Comparision of the long-pulse dye (590-595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectases. Dermatol Surg 2000; 24: 221–6.
  • McDaniel DH, Ash K, Lord J, et al. Laser therapy of spider leg veins: clinical evaluation of a new long pulsed alexandrite laser. Dermatol Surg 1999; 25: 52–8.
  • Reichert D. Evaluation of the long-pulse dye laser for the treatment of leg telangiectases. Dermatol Surg 2000; 24: 737–40.
  • Busher BA, McMeekin TO, Goodwin D. Treatment of leg telangiectasias by using a long-pulsed dye laser at 595 nm with and without dynamic cooling device. Laser Surg Med 2000; 27: 171–5.
  • Goldman MP, Sadick NS, Weiss RA. Treatment of spider veins with the 595nm pulsed-dye laser. J Am Acad Dermatol 2000; 42: 849–50.
  • Adrian RM. Treatment of leg telangiectases using a longpulse frequency doubled neodymium: YAGlaser at 532 nm. Dermatol Surg 2000; 24: 19–23.
  • Bernstein EF, Kornbluth S, Brown DB, Black J. Treatment of spider veins using a 10 millisecond pulse-duration frequency-doubled neodymium YAG laser. Dermatol Surg 1999; 25: 316–20.
  • McMeekin TO. Treatment of spider veins of the leg using a long-pulsed Nd: YAGlaser (Versapulse) at 532 nm. J Cutan Laser Ther 1999; 1: 179–80.
  • Weiss RA, Weiss MA. Early clinical results with a multiple synchronized pulse 1064nm laser for leg telangiectases and reticular veins. Dermatol Surg 1999; 25: 399–402.
  • Sadick NS. Long-term results with a multiple synchronized-pulse 1064nm Nd: YAGlaser for the treatment of leg venulectases and reticular veins. Dermatol Surg 2001; 27: 365–9.
  • Sadick NS, Prieto G, Shea CR, et al. Clinical and pathophysiological correlates of 1064nm Nd: Yaglaser treatment of reticular veins and venulectasias. Arch Dermatol 2001; 137: 613–17.
  • Major A, Brazzini B, Campolmi P, et al. Nd:YAG 1064nm laser in the treatment of facial and leg telangiectases. J Eur Acad Dermatol Venereol 2001; 15: 559–65.
  • Omura NE, Dover JS, Arndt KA, Kauvar ANB. Treatment of reticular leg veins with a 1064nm longpulsed Nd: YAGlaser. J Am Acad Dermatol 2003; 48: 76–81.
  • Varma S, Lanigan SW. Laser therapy of telangiectatic leg veins: clinical evaluation of the 810nm diode laser. Clin Exp Dermatol 2000; 25: 419–22.
  • Weiss RA, Weiss MA. Doppler ultrasound findings in reticular vein of the tight subdermic lateral venous system and implications for sclerotherapy. J Dermatol Surg Oncol 1993; 19: 947–51.
  • Baak JPA, Oort J. A Manual of Morphometry in Diagnostic Pathology Berlin: Springer, 1983.
  • Astafyeva LG, Zheltov GI, Rubanov AS. Modelling of blood vessel heating by laser radiation. Optics and Spectroscopy 2001; 90: 244–9.
  • Dam JS, Pedersen CB, Dalgaard T, et al. Fibre-optic probe for non-invasive real-time determination of tissue optical properties at multiple wavelengths. Appl Optics 2001; 40: 1155–64.
  • Schmidt W-D, Fassler D, Zimmermann G, et al. Noncontacting diffuse VIS-NIR spectroscopy of human skin for evaluation of skin type and time-dependent microcirculation. Proc SPIE 2000; 4160: 91–102.
  • Schmidt W-D, Liebold K, Fassler W-D, Wollina U. Contact-free spectroscopy of leg ulcers: principle, technique, and calculation of spectroscopic wound scores. J Invest Dermatol 2001; 114: 531–5.
  • Weiss RA, Dover JS. Laser surgery of leg veins. Dermatol Clin 2002; 20: 19–36.
  • McCoy S, Hanna M, Anderson P, et al. An evaluation of the copper-bromide laser for treating telangiectasia. Dermatol Surg 1996; 22: 551–7.
  • McCoy SE. Copper bromide laser treatment of facial telangiectasia: results of patients treated over five years. Laser Surg Med 1997; 21: 329–40.
  • Rogachefsky AS, Silapunt S, Goldberg DJ. Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel colour and size. Dermatol Surg 2002; 28: 220–23.
  • Massay RA, Katz BE. Successful treatment of spider leg veins with a high-energy, long-pulse, frequency-doubled neodymium: YAGlaser (HELP-G). Dermatol Surg 1989; 25: 677–80.
  • Eremia S, Do CYL. Treatment of leg and face veins with a cryogen spray variable pulse width 1064-nm Nd: YAGlaser - a prospective study of 47 patients. J Cosmetic Laser Ther 2001; 3: 147–53.
  • Wiek K, Vanscheidt W, Ishkhanian S, et al. Selektive Photothermolyse von Besenreiservarizen und Telangiektasien der unteren Extremität. Hautarzt 1996; 47: 258–63.
  • Barton JK, Frangineas G, Pummer H, Black JF. Cooperative phenomena in two-pulse, two-colour laser photocoagulation of cutaneous blood vessels. Photochem Photobiol 2001; 73: 642–50.
  • Apfelberg DB, Smith T, Maser MR, et al. Study of three laser systems for treatment of superficial varicosities of the lower extremity. Lasers Surg Med 1987; 7: 219–23.
  • Roggan A, Friebel M, Dörschel K, et al. Optical properties of circulating human blood in the wavelength range 400-2500 nm. J Biomed Optics 1999; 4: 36–46.
  • Verkruysse W, Nilsson AMK, Milner TE, et al. Optical absorption of blood depends on temperature during a 0.5 ms laser pulse at 586 nm. Photochem Photobiol 2000; 67: 276–81.
  • Barton JK, Rollins A, Yazdanfar S, et al. Photothermal coagulation of blood vessels: a comparison of high-speed optical coherence tomography and numerical modelling. Phys Med Biol 2001; 46: 1665–78.
  • Tan OT. Ultrastructural changes in red blood cells following pulsed irradiation in vitro. J Invest Dermatol 1989; 92: 100–104.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.